US FDA found ongoing concerns during an April inspection of a Zimmer Biomet facility in Warsaw, Ind., a warning letter posted to the agency’s website on Aug. 28 confirmed.
This is the second warning letter Zimmer has received concerning the North Campus plant in recent years. The facility first...







